225 related articles for article (PubMed ID: 37509122)
21. The change of gut microbiota-derived short-chain fatty acids in diabetic kidney disease.
Zhong C; Dai Z; Chai L; Wu L; Li J; Guo W; Zhang J; Zhang Q; Xue C; Lin H; Luo Q; Cai K
J Clin Lab Anal; 2021 Dec; 35(12):e24062. PubMed ID: 34689373
[TBL] [Abstract][Full Text] [Related]
22. Meprin β metalloproteases associated with differential metabolite profiles in the plasma and urine of mice with type 1 diabetes and diabetic nephropathy.
Gooding J; Cao L; Whitaker C; Mwiza JM; Fernander M; Ahmed F; Acuff Z; McRitchie S; Sumner S; Ongeri EM
BMC Nephrol; 2019 Apr; 20(1):141. PubMed ID: 31023251
[TBL] [Abstract][Full Text] [Related]
23. Assessment of uremic toxins in advanced chronic kidney disease patients on maintenance hemodialysis by LC-ESI-MS/MS.
Ragi N; Pallerla P; Babi Reddy Gari AR; Lingampelly SS; Ketavarapu V; Addipilli R; Chirra N; Kantevari S; Yadla M; Sripadi P
Metabolomics; 2023 Feb; 19(3):14. PubMed ID: 36826619
[TBL] [Abstract][Full Text] [Related]
24. 5-Hydroxyhexanoic Acid Predicts Early Renal Functional Decline in Type 2 Diabetes Patients with Microalbuminuria.
Tang X; You J; Liu D; Xia M; He L; Liu H
Kidney Blood Press Res; 2019; 44(2):245-263. PubMed ID: 31071709
[TBL] [Abstract][Full Text] [Related]
25. Metabolomic comparison followed by cross-validation of enzyme-linked immunosorbent assay to reveal potential biomarkers of diabetic retinopathy in Chinese with type 2 diabetes.
Wang Z; Tang J; Jin E; Ren C; Li S; Zhang L; Zhong Y; Cao Y; Wang J; Zhou W; Zhao M; Huang L; Qu J
Front Endocrinol (Lausanne); 2022; 13():986303. PubMed ID: 36157454
[TBL] [Abstract][Full Text] [Related]
26. Metabolomic profiling of amino acids study reveals a distinct diagnostic model for diabetic kidney disease.
Wang J; Zhou C; Zhang Q; Liu Z
Amino Acids; 2023 Nov; 55(11):1563-1572. PubMed ID: 37736814
[TBL] [Abstract][Full Text] [Related]
27. UPLC-MS-based urine nontargeted metabolic profiling identifies dysregulation of pantothenate and CoA biosynthesis pathway in diabetic kidney disease.
Ma T; Liu T; Xie P; Jiang S; Yi W; Dai P; Guo X
Life Sci; 2020 Oct; 258():118160. PubMed ID: 32730837
[TBL] [Abstract][Full Text] [Related]
28. Urinary metabolites associate with the presence of diabetic kidney disease in type 2 diabetes and mediate the effect of inflammation on kidney complication.
Shi C; Wan Y; He A; Wu X; Shen X; Zhu X; Yang J; Zhou Y
Acta Diabetol; 2023 Sep; 60(9):1199-1207. PubMed ID: 37184672
[TBL] [Abstract][Full Text] [Related]
29. Sacubitril/Valsartan contributes to improving the diabetic kidney disease and regulating the gut microbiota in mice.
Wang P; Guo R; Bai X; Cui W; Zhang Y; Li H; Shang J; Zhao Z
Front Endocrinol (Lausanne); 2022; 13():1034818. PubMed ID: 36589853
[TBL] [Abstract][Full Text] [Related]
30. Identification of Urinary Metabolite Biomarkers of Type 2 Diabetes Nephropathy Using an Untargeted Metabolomic Approach.
Chen CJ; Liao WL; Chang CT; Lin YN; Tsai FJ
J Proteome Res; 2018 Nov; 17(11):3997-4007. PubMed ID: 30265543
[TBL] [Abstract][Full Text] [Related]
31. Intestinal microbiome diversity of diabetic and non-diabetic kidney disease: Current status and future perspective.
Das S; Gnanasambandan R
Life Sci; 2023 Mar; 316():121414. PubMed ID: 36682521
[TBL] [Abstract][Full Text] [Related]
32. Metabolomics as a tool for the early diagnosis and prognosis of diabetic kidney disease.
Pereira PR; Carrageta DF; Oliveira PF; Rodrigues A; Alves MG; Monteiro MP
Med Res Rev; 2022 Jul; 42(4):1518-1544. PubMed ID: 35274315
[TBL] [Abstract][Full Text] [Related]
33. Normoalbuminuric diabetic kidney disease.
Chen C; Wang C; Hu C; Han Y; Zhao L; Zhu X; Xiao L; Sun L
Front Med; 2017 Sep; 11(3):310-318. PubMed ID: 28721497
[TBL] [Abstract][Full Text] [Related]
34. Targeted metabolomics as a tool for the diagnosis of kidney disease in Type II diabetes mellitus.
Abdelsattar S; Kasemy ZA; Elsayed M; Elrahem TA; Zewain SK
Br J Biomed Sci; 2021 Oct; 78(4):184-190. PubMed ID: 33656967
[No Abstract] [Full Text] [Related]
35. Urinary microbiota and serum metabolite analysis in patients with diabetic kidney disease.
Yang Y; Ma C; Li S; Cai W; Dai W; Zhang X; Yin L; Donge Tang ; Liu F; Dai Y
Heliyon; 2023 Aug; 9(8):e17040. PubMed ID: 37521000
[TBL] [Abstract][Full Text] [Related]
36. Integrated biomarker for type 2 diabetes mellitus and impaired fasting glucose based on metabolomics analysis using ultra-high performance liquid chromatography quadrupole-Orbitrap high-resolution accurate mass spectrometry.
Long J; Liu L; Jia Q; Yang Z; Sun Z; Yan C; Yan D
Rapid Commun Mass Spectrom; 2020 Jun; 34(12):e8779. PubMed ID: 32159245
[TBL] [Abstract][Full Text] [Related]
37. Metabolomic Investigation of Blood and Urinary Amino Acids and Derivatives in Patients with Type 2 Diabetes Mellitus and Early Diabetic Kidney Disease.
Mogos M; Socaciu C; Socaciu AI; Vlad A; Gadalean F; Bob F; Milas O; Cretu OM; Suteanu-Simulescu A; Glavan M; Ienciu S; Balint L; Jianu DC; Petrica L
Biomedicines; 2023 May; 11(6):. PubMed ID: 37371622
[TBL] [Abstract][Full Text] [Related]
38. Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography/tandem mass spectrometry.
Kikuchi K; Itoh Y; Tateoka R; Ezawa A; Murakami K; Niwa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Nov; 878(29):2997-3002. PubMed ID: 20870466
[TBL] [Abstract][Full Text] [Related]
39. Gut microbiota profile and selected plasma metabolites in type 1 diabetes without and with stratification by albuminuria.
Winther SA; Henriksen P; Vogt JK; Hansen TH; Ahonen L; Suvitaival T; Hein Zobel E; Frimodt-Møller M; Hansen TW; Hansen T; Parving HH; Legido-Quigley C; Rossing P; Pedersen O
Diabetologia; 2020 Dec; 63(12):2713-2724. PubMed ID: 32886190
[TBL] [Abstract][Full Text] [Related]
40. High-Throughput Metabolomics and Diabetic Kidney Disease Progression: Evidence from the Chronic Renal Insufficiency (CRIC) Study.
Zhang J; Fuhrer T; Ye H; Kwan B; Montemayor D; Tumova J; Darshi M; Afshinnia F; Scialla JJ; Anderson A; Porter AC; Taliercio JJ; Rincon-Choles H; Rao P; Xie D; Feldman H; Sauer U; Sharma K; Natarajan L
Am J Nephrol; 2022; 53(2-3):215-225. PubMed ID: 35196658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
